2026-10-01 06:30
Press release
Omnio raises €2.9 million to advance chronic wound therapy toward clinical trials
Swedish biotech company Omnio AB has raised €2.9 million to advance its plasminogen-based therapy for chronic wounds toward first-in-human clinical...